Information Provided By:
Fly News Breaks for June 23, 2017
RGEN
Jun 23, 2017 | 12:05 EDT
Janney Capital analyst Paul Knight raised his fair value estimate on Repligen to $47 from $42 following the company's agreement to acquire privately-held Spectrum, which the company said is expected to accelerate the growth of its filtration business. Knight keeps a Buy rating on Repligen shares.
News For RGEN From the Last 2 Days
There are no results for your query RGEN